AAAAAA
Results:
1-15
|
Results: 15
Authors:
Rossmanith, T
Schroder, B
Bug, G
Muller, P
Klenner, T
Knaus, R
Hoelzer, D
Ottmann, OG
Citation: T. Rossmanith et al., Interleukin 3 improves the ex vivo expansion of primitive human cord bloodprogenitor cells and maintains the engraftment potential of SCID repopulating cells, STEM CELLS, 19(4), 2001, pp. 313-320
Authors:
Lizio, R
Klenner, T
Sarlikiotis, AW
Romeis, P
Marx, D
Nolte, T
Jahn, W
Borchard, G
Lehr, CM
Citation: R. Lizio et al., Systemic delivery of cetrorelix to rats by a new aerosol delivery system, PHARM RES, 18(6), 2001, pp. 771-779
Authors:
Lizio, R
Westhof, A
Lehr, CM
Klenner, T
Citation: R. Lizio et al., Oral endotracheal intubation of rats for intratracheal instillation and aerosol drug delivery, LAB ANIMALS, 35(3), 2001, pp. 257-260
Authors:
Lizio, R
Marx, D
Nolte, T
Lehr, CM
Sarlikiotis, AW
Borchard, G
Jahn, W
Klenner, T
Citation: R. Lizio et al., Development of a new aerosol delivery system for systemic pulmonary delivery in anaesthetized and orotracheal intubated rats, LAB ANIMALS, 35(3), 2001, pp. 261-270
Authors:
Andreu, T
Ebensperger, C
Westphal, EM
Klenner, T
Stewart, AF
Westhof, A
Muller, P
Knaus, R
von Melchner, H
Citation: T. Andreu et al., Self-deleting suicide vectors (SDSV): Selective killing of p53-deficient cancer cells, CANCER RES, 61(18), 2001, pp. 6925-6930
Authors:
Bacher, G
Nickel, B
Emig, P
Vanhoefer, U
Seeber, S
Shandra, A
Klenner, T
Beckers, T
Citation: G. Bacher et al., D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity, CANCER RES, 61(1), 2001, pp. 392-399
Authors:
Lizio, R
Klenner, T
Borchard, G
Romeis, P
Sarlikiotis, AW
Reissmann, T
Lehr, CM
Citation: R. Lizio et al., Systemic delivery of the GnRH antagonist cetrorelix by intratracheal instillation in anesthetized rats, EUR J PH SC, 9(3), 2000, pp. 253-258
Authors:
Engel, J
Klenner, T
Niemeyer, U
Peter, G
Schussler, M
Schupke, H
Voss, A
Wiessler, M
Citation: J. Engel et al., Glufosfamide. Oncolytic, DNA-damaging drug, nitrogen mustard., DRUG FUTURE, 25(8), 2000, pp. 791-794
Authors:
Engel, J
Hilgard, P
Klenner, T
Kutscher, B
Nossner, G
Traiser, M
Voss, V
Citation: J. Engel et al., Perifosine - Oncolytic - Ether phospholipid, DRUG FUTURE, 25(12), 2000, pp. 1257-1260
Authors:
Lux, H
Heise, N
Klenner, T
Hart, D
Opperdoes, FR
Citation: H. Lux et al., Ether-lipid (alkyl-phospholipid) metabolism and the mechanism of action ofether-lipid analogues in Leishmania, MOL BIOCH P, 111(1), 2000, pp. 1-14
Authors:
Schmidt-Ott, R
Klenner, T
Overath, P
Aebischer, T
Citation: R. Schmidt-ott et al., Topical treatment with hexadecylphosphocholine (Miltex (R)) efficiently reduces parasite burden in experimental cutaneous leishmaniasis, T RS TROP M, 93(1), 1999, pp. 85-90
Authors:
Klenner, T
Engel, J
Hilgard, P
Citation: T. Klenner et al., Alkylphosphocholines: An update - Introduction, DRUGS TODAY, 34, 1998, pp. 1-2
Authors:
Nickel, B
Klenner, T
Hilgard, P
Citation: B. Nickel et al., Identification of antidotes against the gastrointestinal toxicity of alkylphosphocholines, DRUGS TODAY, 34, 1998, pp. 59-65
Authors:
Kaufmann-Kolle, P
Klenner, T
Unger, C
Eibl, H
Citation: P. Kaufmann-kolle et al., Liposomal alkylphosphocholines, DRUGS TODAY, 34, 1998, pp. 107-115
Authors:
Hart, D
Lux, H
Parker, P
Klenner, T
Citation: D. Hart et al., Ether lipid (alkylphospholipid) analogs as antileishmanial drugs, DRUGS TODAY, 34, 1998, pp. 117-131
Risultati:
1-15
|